Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Amplia Therapeutics Ltd banner

Amplia Therapeutics Ltd
ASX:ATX

Watchlist Manager
Amplia Therapeutics Ltd Logo
Amplia Therapeutics Ltd
ASX:ATX
Watchlist
Price: 0.122 AUD 1.67% Market Closed
Market Cap: AU$62.6m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+104%
5Y
+253%
10Y
+1 301%
Liabilities
+
3Y
-42%
5Y
+160%
10Y
+216%
Equity
+
3Y
+125%
5Y
+258%
10Y
+1 502%

Balance Sheet Decomposition
Amplia Therapeutics Ltd

Balance Sheet
Amplia Therapeutics Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
0
0
8
4
3
1
0
1
1
2
15
9
3
11
Cash
0
0
0
0
0
1
0
0
0
0
4
1
0
0
Cash Equivalents
0
0
8
4
3
0
0
1
1
2
11
8
3
11
Short-Term Investments
1
0
0
0
0
5
2
0
0
0
0
0
0
0
Total Receivables
0
0
2
0
2
2
0
0
0
1
2
1
3
4
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
1
0
1
1
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Assets
1
0
5
0
5
7
3
1
1
3
17
11
7
15
PP&E Net
0
0
0
0
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
1
0
0
0
0
1
0
0
0
0
0
0
0
0
Intangible Assets
4
3
1
0
0
0
0
8
8
8
8
8
8
8
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
6
N/A
3
-42%
5
+50%
0
N/A
5
N/A
8
+50%
3
-65%
9
+248%
9
-1%
11
+19%
24
+125%
19
-24%
15
-21%
23
+55%
Liabilities
Accounts Payable
0
0
0
0
0
0
0
1
1
1
0
0
2
2
Accrued Liabilities
0
0
0
0
0
1
0
0
0
0
0
0
0
0
Short-Term Debt
2
3
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
2
2
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
2
3
1
0
1
1
0
1
1
1
1
3
3
2
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
2
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
3
N/A
3
+31%
1
-69%
0
N/A
1
N/A
1
-12%
0
-69%
1
+89%
1
-3%
1
+6%
3
+389%
3
+8%
3
+20%
2
-44%
Equity
Common Stock
97
97
114
0
114
123
123
131
133
137
152
152
152
167
Retained Earnings
94
97
110
0
110
116
119
122
124
126
128
134
140
146
Other Equity
0
0
0
2
0
0
2
0
0
0
2
2
0
0
Total Equity
3
N/A
0
-99%
4
+13 244%
0
N/A
4
N/A
7
+66%
2
-64%
9
+266%
9
-1%
10
+20%
22
+111%
16
-28%
11
-28%
21
+84%
Total Liabilities & Equity
6
N/A
3
-42%
5
+50%
0
N/A
5
N/A
8
+50%
3
-65%
9
+248%
9
-1%
11
+19%
24
+125%
19
-24%
15
-21%
23
+55%
Shares Outstanding
Common Shares Outstanding
18
10
20
0
22
25
25
45
73
109
204
204
204
388

See Also

Summary
ATX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATX stock valuation using valuation multiples.
Wall Street Estimates
ATX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.